Skip to content
Open access

Acid-responsive nanoparticles with microneedles for anti‑inflammatory sonodynamic therapy of gouty arthritis

Oct 2026 · Drug Delivery · Vol 33 · 0 citations · 58 references
Medicine

TL;DR

An acid-responsive curcumin-loaded nanoparticles microneedle system that delivers curcumin with pH-triggered release and anti-inflammatory activity enhances anti-inflammatory efficacy and reduction of M1-associated inflammatory responses, offering an effective approach for AGA therapy.

Abstract

Abstract The pathological microenvironment of acute gouty arthritis (AGA) features local tissue acidification and the release of a storm of pro-inflammatory cytokines. To address this dual challenge, we engineered an acid-responsive curcumin-loaded nanoparticles microneedle system (Cur-PNPs@MN) that delivers curcumin with pH-triggered release and anti-inflammatory activity. This integrated platform combines a hyaluronic acid (HA)-based dissolving microneedle for localized transdermal delivery of acid-degradable PCADK (poly (cyclohexane-1,4-diyl acetone dimethylene ketal)) curcumin nanoparticles (Cur-PNPs), which are designed for pH-triggered curcumin release at the pathological site. Together, they deliver curcumin, a dual-function agent acting both as an anti-inflammatory compound and a nanoenhanced sonosensitizer. In vitro, the system exhibited acid-responsive drug release and also promoted macrophage uptake, achieving significant curcumin accumulation within 1 hour and saturation by 4 hours. Moreover, it could generate potent ultrasound-induced reactive oxygen species (ROS). The ROS generation capability of Cur-PNPs was 1.47-fold higher than that of Cur‑aggregates, resulting in anapoptosis rate of 29.9% in M1 macrophages. In vivo, the chemo-sonodynamic therapy (Cur-PNPs@MN+Ultrasound (US)) in a rat AGA model significantly alleviated joint swelling and inflammatory infiltration, while drastically suppressing pro-inflammatory cytokines, with IL-1β decreasing from 170.3 to 67.3 pg/mL, TNF-α from 20.8 to 5.9 pg/mL, and IL-6 from 140.9 to 48.2 pg/mL, and achieved therapeutic efficacy comparable to conventional drugs. This work demonstrates a synergistic chemo‑sonodynamic strategy by coupling pH-triggered curcumin release with ultrasound-enhanced ROS generation. This acid-responsive therapeutic strategy enhances anti-inflammatory efficacy and reduction of M1-associated inflammatory responses, offering an effective approach for AGA therapy.

Read PDF

Similar papers

Sep 2026

Dissolving Microneedles Loaded with Lipid Nanoparticles for Co-Delivery of siTNF-α and Dexamethasone as a Dual-Action Therapy for Psoriasis.

Psoriasis, a chronic inflammatory skin disease, presents treatment challenges including systemic side effects and inadequate topical drug delivery. Herein, we developed a hyaluronic acid (HA)-based dissolving microneedle platform delivering tumor necrosis factor-alpha (TNF-α)-targeting small interfering RNA (siRNA) and...

Ya-Xin Cheng, Yun-Feng Han, Xue-Ying Gu et al. · 1 citation
Open access Oct 2026

Cu 2 ⁺-responsive hyaluronic acid nanoplatform for targeted curcumin delivery and suppression of osteolysis- and metastasis-related phenotypes in lung adenocarcinoma

Bone metastasis is a major cause of morbidity and mortality in lung adenocarcinoma and is closely associated with epithelial–mesenchymal transition (EMT) and tumor-derived osteolytic factors. Although curcumin exhibits promising anti-tumor and anti-metastatic activities, its poor solubility and low bioavailability li...

Jian-Gang Chen, Ao Xu, Yu-Sheng Tang et al. · 0 citations
Sep 2026

pH-Responsive Hydrogel-Mediated Transdermal Co-delivery of Triamcinolone Acetonide and 5-Fluorouracil for Hypertrophic Scar Treatment via Regulating Macrophage Polarization and Exerting Antifibrotic Effects.

Hypertrophic scar (HS) is a fibrotic disorder caused by imbalanced tissue repair after skin injury. Its core features include persistent inflammation and excessive collagen deposition. Current clinical treatments are limited by poor efficacy, severe local adverse reactions, and low transdermal delivery efficiency of to...

Shi-Sheng Chen, Yuan-Yuan Hu, Hong-Ping Ge et al. · 0 citations
Oct 2026

Engineered Chitosan Nanoparticle Platform Enables Controlled Ibuprofen Delivery and Coordinated Neuroimmune Regulation in a Human Microphysiological Model.

Controlled delivery of anti-inflammatory agents using bioactive nanomaterials offers a strategy to achieve localized and temporally regulated modulation of inflammatory and neurogenic signaling. Here, we engineered an adsorption-based chitosan nanoparticle platform for controlled Ibuprofen delivery to coordinate inflam...

N. Menon, A. Kishen · 0 citations
Open access Oct 2026

Targeted PLGA Nanoparticle Delivery of Mycophenolate Mofetil: A Novel Approach for Sustained Immunosuppression in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that can cause progressive joint damage and disability. Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid, suppresses T- and B-lymphocyte proliferation through inhibition of inosine monophosphate dehydrogenase, but systemic treatment may b...

B. José, V.Sugumarpandi, V.Gunaseelan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.